Purchases and Sales Made in Q3 2022 in Biond Vax Pharmaceuticals Ltd. (BVXV)
This table provides information about the institutional ownership of Biond Vax Pharmaceuticals Ltd. (BVXV) during Q3 2022. The information is specifically focused on institutions that hold shares of BiondVax Pharmaceuticals Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
12.3KNew |
$11.8K - $15.5K
|
12.3K
$7.86K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
3.36K+ 71.55% |
$3.22K - $4.23K
|
8.05K
$5.15K
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
100+ 0.55% |
$96 - $126
|
18.4K
$11.8K
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 04, 2022
Q3 2022
|
True Private Wealth Advisors
|
SELL
|
- |
-8.5K- 15.32% |
$8.16K - $10.7K
|
47K
$30.1K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-10.7K- 32.12% |
$10.3K - $13.5K
|
22.6K
$14.5K
|
|
|
Nov 10, 2022
Q3 2022
|
Envestnet Asset Management Inc
|
SELL
|
- |
-84.2K- 51.53% |
$80.8K - $106K
|
79.2K
$50.7K
|